T48.1X1

Clinical Causes: Accidental ingestion of medications intended for medical use, especially in children or individuals with cognitive impairments Incorrect administration during medical procedures or surgeries Misuse or abuse of muscle relaxants outside of medical supervision Lack of proper storage leading to accidental access Poor labeling or misunderstanding of medication instructions

Key Symptoms: Muscle weakness or paralysis, especially in the respiratory muscles Difficulty breathing or shortness of breath Reduced muscle tone or flaccidity Drop in blood pressure Bradycardia (slow heart rate) Loss of consciousness in severe cases Difficulty speaking or swallowing Possible aspiration due to weakened swallowing reflexes

Diagnosis Path: Diagnosis typically involves reviewing the patient's medical history, medication exposure, and presenting symptoms. Healthcare professionals may perform physical examinations and laboratory tests, such as blood tests, to detect the presence of neuromuscular blocking agents or their metabolites. In some cases, imaging or additional neurological assessments may be necessary to evaluate the extent of muscle paralysis and respiratory compromise.

Treatment Protocols: Immediate treatment focuses on stabilizing the patient's breathing and circulation. Supportive care may include oxygen therapy, mechanical ventilation if breathing is compromised, and monitoring vital signs. Specific interventions can involve the administration of antidotes or medications that can reverse the effects of muscle relaxants, such as cholinesterase inhibitors. In some instances, treatments like activated charcoal may be used if ingestion was recent. Long-term management depends on the severity of poisoning and the presence of any residual neurological or muscular effects.